EP Patent

EP2140860A1 — An improved method of contraception

Assigned to Bayer Oy · Expires 2010-01-06 · 16y expired

What this patent protects

The invention is related to an improved method of contraception, for preventing or suppressing abnormal and/or irregular endometrial bleeding and achieving a rapid induction of amenorrhea by using an intrauterine delivery system comprising pro-gestogen or a drug having a progesto…

USPTO Abstract

The invention is related to an improved method of contraception, for preventing or suppressing abnormal and/or irregular endometrial bleeding and achieving a rapid induction of amenorrhea by using an intrauterine delivery system comprising pro-gestogen or a drug having a progestogenic activity for the controlled release over a prolonged period of time and at a therapeutic level required for contraception, and a sufficient amount of one or more therapeutically active substances capable of suppressing abnormal and/or irregular endometrial bleeding.

Drugs covered by this patent

Patent Metadata

Patent number
EP2140860A1
Jurisdiction
EP
Classification
—
Expires
2010-01-06
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Oy
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.